MHRA (UK)
OTHER
National Patient Safety Alert: ResMed Astral 100 and 150 Ventilators: Potential for Patient Harm due to Unexpected Interruption of Ventilation Therapy (NatPSA/2026/004/MHRA)
Published: 8/17/2026Detected: 9/4/2026
Summary preview
National Patient Safety Alert highlights a safety risk for ResMed Astral 100 and 150 ventilators (and associated Printed Circuit Board Assembly spare parts) manufactured prior to October 2024, where a device fault may…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountrespiratory
safety
clinical
quality
labeling
manufacturing
#MHRA
#National Patient Safety Alert
#Field Safety Notice
#medical device vigilance
#ventilator
Official Source Document Source Verified
Access the original document directly from MHRA.
More from MHRA (UK)
- Class 4 Medicines Defect Notification: Neuraxpharm UK Limited, Levetiracetam Neuraxpharm granules for oral solution in sachet, EL(26)A/4010/1/2026
- Field Safety Notices: 21 to 25 September 20269/29/2026
- MHRA Safety Roundup: September 20269/29/2026
- Class 4 Medicines Defect Notification: B. Braun Melsungen AG, Meropenem 1000 mg powder and solvent for solution for infusion, EL(26)A/399/23/2026
- Field Safety Notices: 14 to 18 September 20269/23/2026